Lundbeck
HLUN-B.CO
#2099
Rank
NZ$16.02 B
Marketcap
NZ$16.15
Share price
-2.27%
Change (1 day)
32.55%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

EPS for Lundbeck (HLUN-B.CO)

EPS in 2026 (TTM): NZ$1.31

According to Lundbeck's latest financial reports the company's current EPS (TTM) is NZ$1.38. In 2025 the company made an earnings per share (EPS) of NZ$0.92 an increase over its 2024 EPS that were of NZ$0.80.

EPS history for Lundbeck from 2004 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$1.3142.03%
2025NZ$0.9214.5%
2024NZ$0.8029.29%
2023NZ$0.6223.09%
2022NZ$0.5137.26%
2021NZ$0.37-84.61%
2020NZ$2.39-24.61%
2019NZ$3.18-42.06%
2018NZ$5.4840.7%
2017NZ$3.90146.26%
2016NZ$1.58-120.48%
2015NZ-$7.723231.32%
2014NZ-$0.23-115.78%
2013NZ$1.47-23.36%
2012NZ$1.92-48.01%
2011NZ$3.69-9.68%
2010NZ$4.0813.72%
2009NZ$3.5924.32%
2008NZ$2.89-6.05%
2007NZ$3.0781.77%
2006NZ$1.69-16.76%
2005NZ$2.03-17.58%
2004NZ$2.46